Home
This site is intended for healthcare professionals
Advertisement

What next after Metformin - New guidelines

Share
Advertisement
Advertisement
 
 
 

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

What next after Metformin? – New guidelines th 13 July 2022 @ 6pm Judy Downey RGN BSc hons Independent Diabetes Nurse Consultant @Lwnurses #LWN #LearnWithNurses Associate Trainer Education for Health UniversityLecturer New South Bucks Author Practice Nurse Journal Diabetes SocietyMember Primary Care @DowneyJude2757 Using Medall To get slides To get certificateMedall.org Live chat for any problems getting certificates/slidesClosed FB group & PageNG28 Update February 2022 – What has changed? •The need for treatment individualisation has been emphasised and is now supported by a downloadable patient decision aid. •Where possible, SGLT2 inhibitors are now recommended first-line, as dual therapy with metformin, in any individual with atherosclerotic cardiovascular disease, chronic heart failure or high risk of cardiovascular disease. •GLP-1 RAs remain a fourthline option for glycaemic control, which puts the NICE guideline at odds with most other international guidelines.Mr C Father had MI aged 56 Cholesterol/HDL ratio 4.8 Qrisk score of 58% Age (years): 52 BMI (kg/m ): 29 Type 2 diabetes Newly diagnosed diagnosed: HbA 1c 68 mmol/mol (8.4%) Diabetes medication: N/A eGFR (ml/min): 90 Lipids (mmol/L): TC 4.8 HDL 1.0 LDL 3.0 TG 2.2 Blood pressure (mmHg): 158/88 Ethnicity: SouthAsian Lifestyle: Smokes 10/day; 20 units alcohol/week; eats out regularly Occupation: Accountant Mr C What happens next?Communicating risk to patients Mr C 6 MONTHS LATER Using Updated NICE Guidelines Commence Dapagliflozin soon after Metformin Age (years): 52 BMI (kg/m ): 29 Type 2 diabetes diagnosed: 6 months HbA : 68 62 mmol/mol (7.8%) 1c Diabetes medication: Metformin 1000 mg bd Dapagliflozin 10 mg eGFR (ml/min): 90 Lipids (mmol/L): TC LDL TG 1.8 Atorvastatin 20mg 4.0 HDL 1.2 2.7 OD Blood pressure (mmHg): 129/82 Lisinopril 10mg Ethnicity: SouthAsian Lifestyle: Smokes 10/day; 20 units alcohol/week; eats out regularly Occupation: Accountant Mr 1 year after diagnosis C Cholesterol/HDL ratio 3.3 Qrisk score of 37.4 Age (years): 53 BMI (kg/m ): 29 26 Type 2 diabetes 12 months diagnosed: HbA 1c 62 mmol/mol 54 mmol/mol (7.1%) Diabetes medication: Metformin 1000 mg bd; Dapagliflozin 10 mg eGFR (ml/min): 85 Lipids (mmol/L): TC 4.0 HDL 1.2 LDL 2.7 TG 1.8 Blood pressure 125/80 (mmHg): Lifestyle: Smokes 10/day; 20 units alcohol/week; eats out regularly Occupation: Accountant Resources • https://www.nice.org.uk/guidance/ng28 • Management of Type 2 Diabetes 2018. A Consensus Report by ADA and EASD • Phcuk.org – resources – Sugar Infographics • Trend-uk.org – patient information leaflets • Diabetes.org.uk – professionals – Information Prescriptions • Lowcarbprogram.com – 40 day Kickstart Programme • Carbs and Cals World Foods • GP Notebookeducation.com